The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Computational study for suppression of CD25/IL-2 interaction
Abstract
Cancer recurrence presents a huge challenge in cancer patient management. Immune escape is a key mechanism of cancer progression and metastatic dissemination. CD25 is expressed in regulatory T (Treg) cells including tumor-infiltrating Treg cells (TI-Tregs). These cells specially activate and reinforce immune escape mechanism of cancers. The suppression of CD25/IL-2 interaction would be useful against Treg cells activation and ultimately immune escape of cancer. Here, software, web servers and databases were used, at which in silico designed small interfering RNAs (siRNAs), de novo designed peptides and virtual screened small molecules against CD25 were introduced for the prospect of eliminating cancer immune escape and obtaining successful treatment. We obtained siRNAs with low off-target effects. Further, small molecules based on the binding homology search in ligand and receptor similarity were introduced. Finally, the critical amino acids on CD25 were targeted by a de novo designed peptide with disulfide bond. Hence we introduced computational-based antagonists to lay a foundation for further in vitro and in vivo studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ge, W., Ma, X., Li, X., Wang, Y., Li, C., Meng, H., Liu, X., Yu, Z., You, S., & Qiu, L. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.01.007 · Cited by 44
Research works printed but not linked: 67
- Al-Qahtani, D., Anil, S., and Rajendran, R. (2011). Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma. J. Oral Pathol. Med. 40: 636–642. https://doi.org/10.1111/j.1600-0714.2011.01020.x. · DOI
- Amor, K.T., Ryan, C., and Menter, A. (2010). The use of cyclosporine in dermatology: part I. J. Am. Acad. Dermatol. 63: 925–946. https://doi.org/10.1016/j.jaad.2010.02.063. · doi:10.1016/j.jaad.2010.02.063
- Arkin, M.R., Randal, M., DeLano, W.L., Hyde, J., Luong, T.N., Oslob, J.D., Raphael, D.R., Taylor, L., Wang, J., McDowell, R.S., et al.. (2003). Binding of small molecules to an adaptive protein-protein interface. Proc. Natl. Acad. Sci. U.S.A. 100: 1603–1608. https://doi.org/10.1073/pnas.252756299. · DOI · Paper page
- Bates, G.J., Fox, S.B., Han, C., Leek, R.D., Garcia, J.F., Harris, A.L., and Banham, A.H. (2006). Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J. Clin. Oncol. 24: 5373–5380. https://doi.org/10.1200/jco.2006.05.9584. · DOI · Paper page
- Blaszczyk, M., Kurcinski, M., Kouza, M., Wieteska, L., Debinski, A., Kolinski, A., and Kmiecik, S. (2016). Modeling of protein-peptide interactions using the CABS-dock web server for binding site search and flexible docking. Methods 93: 72–83. https://doi.org/10.1016/j.ymeth.2015.07.004. · DOI
- Chaudhary, B. and Elkord, E. (2016). Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting. Vaccines 4: 28. https://doi.org/10.3390/vaccines4030028. · DOI · Paper page
- Chernikov, I.V., Vlassov, V.V., and Chernolovskaya, E.L. (2019). Current development of siRNA bioconjugates: from research to the clinic. Front. Pharmacol. 10: 444. https://doi.org/10.3389/fphar.2019.00444. · DOI · Paper page
- Ciemny, M.P., Debinski, A., Paczkowska, M., Kolinski, A., Kurcinski, M., and Kmiecik, S. (2016). Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction. Sci. Rep. 6: 37532. https://doi.org/10.1038/srep37532. · DOI
- Ciemny, M.P., Kurcinski, M., Kozak, K.J., Kolinski, A., and Kmiecik, S. (2017). Highly flexible protein–peptide docking using CABS-dock. In: Modeling peptide–protein interactions. New York, NY: Humana Press, pp. 69–94. · DOI
- Coles, S.J., Hills, R.K., Wang, E.C.Y., Burnett, A.K., Man, S., Darley, R.L., and Tonks, A. (2012). Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3+ regulatory T cells. Leukemia 26: 2146–2148. https://doi.org/10.1038/leu.2012.75. · doi:10.1038/leu.2012.75
- Curiel, T.J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J.R., Zhang, L., Burow, M., et al.. (2004). Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942–949. https://doi.org/10.1038/nm1093. · DOI · Paper page
- Curti, A., Trabanelli, S., Onofri, C., Aluigi, M., Salvestrini, V., Ocadlikova, D., Evangelisti, C., Rutella, S., De Cristofaro, R., Ottaviani, E., et al. (2010). Indoleamine 2, 3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. Haematologica 95: 2022–2030. https://doi.org/10.3324/haematol.2010.025924. · DOI
- de Vries, S.J., Rey, J., Schindler, C.E., Zacharias, M., and Tuffery, P. (2017). The pepATTRACT web server for blind, large-scale peptide-protein docking. Nucl. Acids Res. 45: W361–W364. https://doi.org/10.1093/nar/gkx335. · DOI
- deLeeuw, R.J., Kost, S.E., Kakal, J.A., and Nelson, B.H. (2012). The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin. Canc. Res. 18: 3022–3029. https://doi.org/10.1158/1078-0432.ccr-11-3216. · DOI · Paper page
- Duell, J., Dittrich, M., Bedke, T., Mueller, T., Eisele, F., Rosenwald, A., Rasche, L., Hartmann, E., Dandekar, T., Einsele, H., et al. (2017). Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL. Leukemia 31: 2181–2190. https://doi.org/10.1038/leu.2017.41. · DOI · Paper page
- Dundas, J., Ouyang, Z., Tseng, J., Binkowski, A., Turpaz, Y., and Liang, J. (2006). CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucl. Acids Res. 34: W116–W118. https://doi.org/10.1093/nar/gkl282. · DOI · Paper page
- Ekins, S., Mestres, J., and Testa, B. (2007). In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br. J. Pharmacol. 152: 9–20. https://doi.org/10.1038/sj.bjp.0707305. · DOI · Paper page
- Gao, Q., Qiu, S.J., Fan, J., Zhou, J., Wang, X.Y., Xiao, Y.S., Xu, Y., Li, Y.W., and Tang, Z.Y. (2007). Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 25: 2586–2593. https://doi.org/10.1200/jco.2006.09.4565. · DOI · Paper page
- Garcia-Garcia, J., Guney, E., Aragues, R., Planas-Iglesias, J., and Oliva, B. (2010). Biana: a software framework for compiling biological interactions and analyzing networks. BMC Bioinf. 11: 56. https://doi.org/10.1186/1471-2105-11-56. · DOI
- Garcia-Garcia, J., Valls-Comamala, V., Guney, E., Andreu, D., Muñoz, F.J., Fernandez-Fuentes, N., and Oliva, B. (2017). iFrag: a protein-protein interface prediction server based on sequence fragments. J. Mol. Biol. 429: 382–389. https://doi.org/10.1016/j.jmb.2016.11.034. · DOI
- Goodman, W.A., Cooper, K.D., and McCormick, T.S. (2012). Regulation generation: the suppressive functions of human regulatory T cells. Crit. Rev. Immunol. 32, https://doi.org/10.1615/critrevimmunol.v32.i1.40. · DOI
- Jackson, A.L., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M., Li, B., Cavet, G., and Linsley, P.S. (2003). Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21: 635–637. https://doi.org/10.1038/nbt831. · DOI · Paper page
- Jiang, Y., Du, Z., Yang, F., Di, Y., Li, J., Zhou, Z., Pillarisetty, V.G., and Fu, D. (2014). FOXP3+ lymphocyte density in pancreatic cancer correlates with lymph node metastasis. PLoS One 9: e106741. https://doi.org/10.1371/journal.pone.0106741. · DOI
- Jiménez-García, B., Pons, C., and Fernández-Recio, J. (2013). pyDockWEB: a web server for rigid-body protein-protein docking using electrostatics and desolvation scoring. Bioinformatics 29: 1698–1699. https://doi.org/10.1093/bioinformatics/btt262. · DOI · Paper page
- Kawabata, T. and Go, N. (2007). Detection of pockets on protein surfaces using small and large probe spheres to find putative ligand binding sites. Proteins 68: 516–529. https://doi.org/10.1002/prot.21283. · DOI
- Kindlund, B., Sjöling, Å., Yakkala, C., Adamsson, J., Janzon, A., Hansson, L.E., Hermansson, M., Janson, P., Winqvist, O., and Lundin, S.B. (2017). CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β. Gastric Cancer 20: 116–125. https://doi.org/10.1007/s10120-015-0591-z. · DOI
- Klebe, G. (2006). Virtual ligand screening: strategies, perspectives and limitations. Drug Discov. Today 11: 580–594. https://doi.org/10.1016/j.drudis.2006.05.012. · DOI · Paper page
- Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al.. (2010). DrugBank 3.0: a comprehensive resource for ’omics’ research on drugs. Nucl. Acids Res. 39: D1035–D1041.https://doi.org/10.1093/nar/gkq1126. · DOI · Paper page
- Kurcinski, M., Jamroz, M., Blaszczyk, M., Kolinski, A., and Kmiecik, S. (2015). CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site. Nucl. Acids Res. 43: W419–W424. https://doi.org/10.1093/nar/gkv456. · DOI · Paper page
- Scognamiglio, P.L., Di Natale, C., Perretta, G., and Marasco, D. (2013). From peptides to small molecules: an intriguing but intricated way to new drugs. Curr. Med. Chem. 20: 3803–3817. https://doi.org/10.2174/09298673113209990184. · DOI
- Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A.C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al.. (2014). DrugBank 4.0: shedding new light on drug metabolism. Nucl. Acids Res. 42: D1091–D1097. https://doi.org/10.1093/nar/gkt1068. · DOI · Paper page
- Lee, G.R. (2017). Phenotypic and functional properties of tumor-infiltrating regulatory T cells. Mediat. Inflamm. 2017: 1–9, doi:https://doi.org/10.1155/2017/5458178. · DOI
- Leffers, N., Gooden, M.J., de Jong, R.A., Hoogeboom, B.N., Klaske, A., Hollema, H., Boezen, H.M., van der Zee, A.G., Daemen, T., and Nijman, H.W. (2009). Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Canc. Immunol. Immunother. 58: 449. https://doi.org/10.1007/s00262-008-0583-5. · DOI · Paper page
- Li, W. and Godzik, A. (2006). Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22: 1658–1659. https://doi.org/10.1093/bioinformatics/btl158. · DOI · Paper page
- Liang, Y.J., Liu, H.C., Su, Y.X., Zhang, T.H., Chu, M., Liang, L.Z., and Liao, G.Q. (2011). Foxp3 expressed by tongue squamous cell carcinoma cells correlates with clinicopathologic features and overall survival in tongue squamous cell carcinoma patients. Oral Oncol. 47: 566–570. https://doi.org/10.1016/j.oraloncology.2011.04.017. · DOI
- Lin, Y.C., Mahalingam, J., Chiang, J.M., Su, P.J., Chu, Y.Y., Lai, H.Y., Fang, J.H., Huang, C.T., Chiu, C.T., and Lin, C.Y. (2013). Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer. Int. J. Canc. 132: 1341–1350. https://doi.org/10.1002/ijc.27784. · DOI
- Litfin, T., Zhou, Y., and Yang, Y. (2017). SPOT-ligand 2: improving structure-based virtual screening by binding-homology search on an expanded structural template library. Bioinformatics 33: 1238–1240. https://doi.org/10.1093/bioinformatics/btw829. · DOI
- Naito, Y., Yamada, T., Ui-Tei, K., Morishita, S., and Saigo, K. (2004). siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic Acids Res. 32: W124–W129. https://doi.org/10.1093/nar/gkh442. · DOI · Paper page
- Naito, Y., Yoshimura, J., Morishita, S., and Ui-Tei, K. (2009). siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect. BMC Bioinf. 10: 1–8. https://doi.org/10.1186/1471-2105-10-392. · DOI · Paper page
- Pellecchia, M. (2013). Antagonists of protein-protein interactions made easy? J. Med. Chem. 56: 13–14. https://doi.org/10.1021/jm301837n. · DOI
- Rickert, M., Wang, X., Boulanger, M.J., Goriatcheva, N., and Garcia, K.C. (2005). The structure of interleukin-2 complexed with its alpha receptor. Science 308: 1477–1480. https://doi.org/10.1126/science.1109745. · DOI · Paper page
- Robb, R.J., Rusk, C.M., and Neeper, M.P. (1988). Structure-function relationships for the interleukin 2 receptor: location of ligand and antibody binding sites on the Tac receptor chain by mutational analysis. Proc. Natl. Acad. Sci. U.S.A. 85: 5654–5658. https://doi.org/10.1073/pnas.85.15.5654. · DOI
- Sauve, K., Nachman, M., Spence, C., Bailon, P., Campbell, E., Tsien, W.H., Kondas, J.A., Hakimi, J., and Ju, G. (1991). Localization in human interleukin 2 of the binding site to the alpha chain (p55) of the interleukin 2 receptor. Proc. Natl. Acad. Sci. U.S.A. 88: 4636–4640. https://doi.org/10.1073/pnas.88.11.4636. · DOI
- Sayour, E.J., McLendon, P., McLendon, R., De Leon, G., Reynolds, R., Kresak, J., Sampson, J.H., and Mitchell, D.A. (2015). Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Canc. Immunol. Immunother. 64: 419–427. https://doi.org/10.1007/s00262-014-1651-7. · DOI · Paper page
- Tao, H., Mimura, Y., Aoe, K., Kobayashi, S., Yamamoto, H., Matsuda, E., Okabe, K., Matsumoto, T., Sugi, K., and Ueoka, H. (2012). Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Lung Canc. 75: 95–101. https://doi.org/10.1016/j.lungcan.2011.06.002. · DOI · Paper page
- Schindler, C.E., de Vries, S.J., and Zacharias, M. (2015). Fully blind peptide-protein docking with pepATTRACT. Structure 23: 1507–1515. https://doi.org/10.1016/j.str.2015.05.021. · DOI
- Schmidtke, P., Le Guilloux, V., Maupetit, J., and Tuffery, P. (2010). Fpocket: online tools for protein ensemble pocket detection and tracking. Nucl. Acids Res. 38: W582–W589. https://doi.org/10.1093/nar/gkq383. · DOI · Paper page
- Shah, W., Yan, X., Jing, L., Zhou, Y., Chen, H., and Wang, Y. (2011). A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+ FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell. Mol. Immunol. 8: 59–66. https://doi.org/10.1038/cmi.2010.56. · DOI · Paper page
- Shang, B., Liu, Y., Jiang, S.J., and Liu, Y. (2015). Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci. Rep. 5: 15179. https://doi.org/10.1038/srep15179. · DOI · Paper page
- Shimizu, J., Yamazaki, S., and Sakaguchi, S. (1999). Induction of tumor immunity by removing CD25+ CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163: 5211–5218. · DOI · Paper page
- Shirley, M. (2017). Daclizumab: a review in relapsing multiple sclerosis. Drugs 77: 447–458. https://doi.org/10.1007/s40265-017-0708-2. · DOI
- Shoichet, B.K. (2004). Virtual screening of chemical libraries. Nature 432: 862–865. https://doi.org/10.1038/nature03197. · DOI · Paper page
- Strauss, L., Bergmann, C., Gooding, W., Johnson, J.T., and Whiteside, T.L. (2007). The frequency and suppressor function of CD4+ CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin. Canc. Res. 13: 6301–6311. https://doi.org/10.1158/1078-0432.ccr-07-1403. · DOI · Paper page
- Tilley, J.W., Chen, L., Fry, D.C., Emerson, S.D., Powers, G.D., Biondi, D., Varnell, T., Trilles, R., Guthrie, R., Mennona, F., et al.. (1997). Identification of a small molecule inhibitor of the IL-2/IL-2R? receptor interaction which binds to IL-2. J. Am. Chem. Soc. 119: 7589–7590. https://doi.org/10.1021/ja970702x. · DOI
- Ui-Tei, K., Naito, Y., Nishi, K., Juni, A., and Saigo, K. (2008). Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect. Nucl. Acids Res. 36: 7100–7109. https://doi.org/10.1093/nar/gkn902. · DOI · Paper page
- Vagner, J., Qu, H., and Hruby, V.J. (2008). Peptidomimetics, a synthetic tool of drug discovery. Curr. Opin. Chem. Biol. 12: 292–296. https://doi.org/10.1016/j.cbpa.2008.03.009. · DOI · Paper page
- Volkamer, A., Kuhn, D., Grombacher, T., Rippmann, F., and Rarey, M. (2012). Combining global and local measures for structure-based druggability predictions. J. Chem. Inf. Model. 52: 360–372. https://doi.org/10.1021/ci200454v. · DOI · Paper page
- Volkamer, A., Kuhn, D., Rippmann, F., and Rarey, M. (2012). DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics 28: 2074–2075. https://doi.org/10.1093/bioinformatics/bts310. · DOI · Paper page
- Weiss, L., Melchardt, T., Egle, A., Grabmer, C., Greil, R., and Tinhofer, I. (2011). Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia. Cancer 117: 2163–2169. https://doi.org/10.1002/cncr.25752. · DOI
- Wishart, D.S., Feunang, Y.D., Guo, A.C., Lo, E.J., Marcu, A., Grant, J.R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al.. (2018). DrugBank 5.0: a major update to the DrugBank database for 2018. Nucl. Acids Res. 46: D1074–D1082. https://doi.org/10.1093/nar/gkx1037. · DOI · Paper page
- Wishart, D.S., Knox, C., Guo, A.C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., and Hassanali, M. (2008). DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucl. Acids Res. 36: D901–D906. https://doi.org/10.1093/nar/gkm958. · DOI · Paper page
- Kawabata, T. (2010). Detection of multiscale pockets on protein surfaces using mathematical morphology. Proteins 78: 1195–1211. https://doi.org/10.1002/prot.22639. · DOI · Paper page
- Wu, Z., Johnson, K.W., Goldstein, B., Choi, Y., Eaton, S.F., Laue, T.M., and Ciardelli, T.L. (1995). Solution assembly of a soluble, heteromeric, high affinity interleukin-2 receptor complex. J. Biol. Chem. 270: 16039–16044. https://doi.org/10.1074/jbc.270.27.16039. · DOI
- Yang, Y., Zhan, J., and Zhou, Y. (2016). SPOT-Ligand: fast and effective structure-based virtual screening by binding homology search according to ligand and receptor similarity. J. Comput. Chem. 37: 1734–1739. https://doi.org/10.1002/jcc.24380. · DOI
- Yang, Z.Z., Novak, A.J., Stenson, M.J., Witzig, T.E., and Ansell, S.M. (2006). Intratumoral CD4+ CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107: 3639–3646. https://doi.org/10.1182/blood-2005-08-3376. · DOI · Paper page
- Yuan, X.L., Chen, L., Li, M.X., Dong, P., Xue, J., Wang, J., Zhang, T.T., Wang, X.A., Zhang, F.M., Ge, H.L., et al.. (2010). Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin. Immunol. 134: 277–288. https://doi.org/10.1016/j.clim.2009.10.005. · DOI
- Zhou, Q., Munger, M.E., Highfill, S.L., Tolar, J., Weigel, B.J., Riddle, M., Sharpe, A.H., Vallera, D.A., Azuma, M., Levine, B.L., et al.. (2010). Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood 116: 2484–2493. https://doi.org/10.1182/blood-2010-03-275446. · DOI · Paper page
Metadata
- Authors
- Dehbashi, M., Hojati, Z., Motovali-bashi, M., Ganjalikhani-Hakemi, M., Shimosaka, A., & Cho, W. C.
- Venue
- Biological Chemistry
- Publisher
- Walter de Gruyter GmbH
- Published
- 2020-11-19
- Volume
- 402
- Issue
- 2
- Pages
- 167-178
- ISSN
- 1437-4315
- 1431-6730
- Cited by
- 0
- References
- 1
- Language
- en
- Funders
- The Graduate Office of University of Isfahan (8489)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Computational study for suppression of CD25/IL-2 interaction. https://app.cochat.ai/papers/10.1515/hsz-2020-0326
- The paper
- Dehbashi, M., Hojati, Z., Motovali-bashi, M., Ganjalikhani-Hakemi, M., Shimosaka, A., & Cho, W. C. (2021). Computational study for suppression of CD25/IL-2 interaction. Biological Chemistry. https://doi.org/10.1515/hsz-2020-0326
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.